speb/financial-data huggingface dataset:
CRNX income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 925000.00
CRNX cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: 0.00
CRNX income_statement (quarterly, 2025-03-31) — Research And Development: 76240000.00
CRNX balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 500000.00
CRNX balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -1048884000.00
CRNX cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 306482000.00
CRNX income_statement (quarterly, 2025-03-31) — Selling General And Administration: 35526000.00
CRNX balance_sheet (quarterly, 2025-03-31) — Share Issued: 93525000.00
CRNX cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 20478000.00
CRNX balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 1254000000.00
CRNX balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 1254000000.00
CRNX income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
CRNX income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.00
CRNX balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 74000.00
CRNX balance_sheet (quarterly, 2025-03-31) — Total Assets: 1361327000.00
CRNX balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 1254000000.00
CRNX balance_sheet (quarterly, 2025-03-31) — Total Debt: 50819000.00
CRNX balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 1254000000.00
CRNX income_statement (quarterly, 2025-03-31) — Total Expenses: 111766000.00
CRNX balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 107327000.00
CRNX balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 70272000.00
CRNX balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 50016000.00
CRNX income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -111405000.00
CRNX balance_sheet (quarterly, 2025-03-31) — Working Capital: 1233744000.00
CRNX income_statement (quarterly, 2025-06-30) — +Operating Expense: 130143000.00
CRNX income_statement (quarterly, 2025-06-30) — +Total Revenue: 1031000.00
CRNX balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 11325000.00
CRNX balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -9586000.00
CRNX cash_flow (quarterly, 2025-06-30) — Amortization Of Securities: -4714000.00
CRNX income_statement (quarterly, 2025-06-30) — Basic Average Shares: 93791000.00
CRNX income_statement (quarterly, 2025-06-30) — Basic EPS: -1.23
CRNX cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 95869000.00
CRNX cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -3202000.00
CRNX balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 49936000.00
CRNX balance_sheet (quarterly, 2025-06-30) — Capital Stock: 2334538000.00
CRNX balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 53726000.00
CRNX balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 1196360000.00
CRNX cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 7055000.00
CRNX cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: 37953000.00
CRNX cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -85851000.00
CRNX cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: -883000.00
CRNX cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: -623000.00
CRNX cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 12516000.00
CRNX cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: -4408000.00
CRNX cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 6602000.00
CRNX cash_flow (quarterly, 2025-06-30) — Changes In Cash: -40843000.00
CRNX balance_sheet (quarterly, 2025-06-30) — Common Stock: 2334538000.00
CRNX balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 1171526000.00
CRNX cash_flow (quarterly, 2025-06-30) — Common Stock Issuance: 0.00
CRNX balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 26761000.00
CRNX balance_sheet (quarterly, 2025-06-30) — Current Assets: 1217264000.00
CRNX balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 6610000.00
CRNX balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 6610000.00
CRNX balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 1904000.00
CRNX balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 1904000.00
CRNX balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 68396000.00
CRNX cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 959000.00
CRNX cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 959000.00
CRNX income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 93791000.00
CRNX income_statement (quarterly, 2025-06-30) — Diluted EPS: -1.23
CRNX income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -115637000.00
CRNX income_statement (quarterly, 2025-06-30) — EBIT: -129112000.00
CRNX income_statement (quarterly, 2025-06-30) — EBITDA: -128153000.00
CRNX income_statement (quarterly, 2025-06-30) — Earnings From Equity Interest: 0.00
CRNX cash_flow (quarterly, 2025-06-30) — Earnings Losses From Equity Investments: 0.00
CRNX cash_flow (quarterly, 2025-06-30) — End Cash Position: 55026000.00
CRNX cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 7055000.00
CRNX cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -89053000.00
CRNX cash_flow (quarterly, 2025-06-30) — Gain Loss On Sale Of PPE: 23000.00
CRNX balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 1621000.00
CRNX income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 49842000.00
CRNX balance_sheet (quarterly, 2025-06-30) — Gross PPE: 66158000.00
CRNX income_statement (quarterly, 2025-06-30) — Interest Income: 13455000.00
CRNX income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 13455000.00
CRNX balance_sheet (quarterly, 2025-06-30) — Invested Capital: 1171526000.00
CRNX cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: 37953000.00
CRNX cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: 0.00
CRNX balance_sheet (quarterly, 2025-06-30) — Leases: 13296000.00
CRNX balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 43326000.00
CRNX balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 43326000.00
CRNX balance_sheet (quarterly, 2025-06-30) — Machinery Furniture Equipment: 2265000.00
CRNX cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: 0.00
CRNX income_statement (quarterly, 2025-06-30) — Net Income: -115637000.00
CRNX income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -115637000.00
CRNX income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -115637000.00
CRNX income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -115637000.00
CRNX income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -115637000.00
CRNX cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -115637000.00
CRNX income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -115637000.00
CRNX income_statement (quarterly, 2025-06-30) — Net Interest Income: 13455000.00
CRNX cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 41155000.00
CRNX income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 13455000.00
CRNX balance_sheet (quarterly, 2025-06-30) — Net PPE: 56572000.00
CRNX cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -3202000.00
CRNX balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 1171526000.00
CRNX balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 3992000.00
CRNX balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Revenue: 3992000.00
CRNX income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -128153000.00
CRNX income_statement (quarterly, 2025-06-30) — Normalized Income: -115637000.00
CRNX cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -85851000.00
CRNX cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: 23000.00
CRNX income_statement (quarterly, 2025-06-30) — Operating Income: -129112000.00
CRNX income_statement (quarterly, 2025-06-30) — Operating Revenue: 1031000.00
CRNX balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 94126000.00
CRNX balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 20404000.00
CRNX balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: 1621000.00
CRNX balance_sheet (quarterly, 2025-06-30) — Other Equity Interest: -112000.00
CRNX income_statement (quarterly, 2025-06-30) — Other Gand A: 49842000.00
CRNX income_statement (quarterly, 2025-06-30) — Other Income Expense: 20000.00
CRNX cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 792000.00
CRNX balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 15738000.00
CRNX balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 2334000.00
CRNX income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 20000.00
CRNX balance_sheet (quarterly, 2025-06-30) — Other Properties: 50597000.00
CRNX balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 1142634000.00
CRNX balance_sheet (quarterly, 2025-06-30) — Payables: 11325000.00
CRNX balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 38086000.00
CRNX balance_sheet (quarterly, 2025-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 21796000.00
CRNX balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 0.00
CRNX income_statement (quarterly, 2025-06-30) — Pretax Income: -115637000.00
CRNX cash_flow (quarterly, 2025-06-30) — Proceeds From Stock Option Exercised: 7055000.00
CRNX balance_sheet (quarterly, 2025-06-30) — Properties: 0.00
CRNX cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -182877000.00
CRNX cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -3202000.00
CRNX income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 959000.00
CRNX income_statement (quarterly, 2025-06-30) — Research And Development: 80301000.00
CRNX balance_sheet (quarterly, 2025-06-30) — Restricted Cash: 500000.00
CRNX balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -1164521000.00
CRNX cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 224032000.00
CRNX income_statement (quarterly, 2025-06-30) — Selling General And Administration: 49842000.00
CRNX balance_sheet (quarterly, 2025-06-30) — Share Issued: 94126000.00
CRNX cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 26124000.00
CRNX balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 1171526000.00
CRNX balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 1171526000.00
CRNX income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
CRNX income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.00
CRNX balance_sheet (quarterly, 2025-06-30) — Total Assets: 1289574000.00
CRNX balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 1171526000.00
CRNX balance_sheet (quarterly, 2025-06-30) — Total Debt: 49936000.00
CRNX balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 1171526000.00
CRNX income_statement (quarterly, 2025-06-30) — Total Expenses: 130143000.00
CRNX balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 118048000.00
CRNX balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 72310000.00
CRNX balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 49652000.00
CRNX income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -129112000.00
CRNX balance_sheet (quarterly, 2025-06-30) — Working Capital: 1148868000.00
CRNX income_statement (quarterly, 2025-09-30) — +Operating Expense: 142729000.00
CRNX income_statement (quarterly, 2025-09-30) — +Total Revenue: 143000.00
CRNX balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 6109000.00
CRNX balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -7043000.00
CRNX cash_flow (quarterly, 2025-09-30) — Amortization Of Securities: -3601000.00
CRNX income_statement (quarterly, 2025-09-30) — Basic Average Shares: 94215000.00
CRNX income_statement (quarterly, 2025-09-30) — Basic EPS: -1.38
CRNX cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 55026000.00
CRNX cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -863000.00
CRNX balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 49144000.00
CRNX balance_sheet (quarterly, 2025-09-30) — Capital Stock: 2364699000.00
CRNX balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 110901000.00
CRNX balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 1092291000.00
CRNX cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 3084000.00
CRNX cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: 164809000.00
CRNX cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -110718000.00
CRNX cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: -792000.00
CRNX cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: -144000.00
CRNX cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 6647000.00
CRNX cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: -7206000.00
CRNX cash_flow (quarterly, 2025-09-30) — Change In Working Capital: -1495000.00
CRNX cash_flow (quarterly, 2025-09-30) — Changes In Cash: 57175000.00
CRNX balance_sheet (quarterly, 2025-09-30) — Common Stock: 2364699000.00
CRNX balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 1072169000.00
CRNX cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 0.00
CRNX balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 27565000.00
CRNX balance_sheet (quarterly, 2025-09-30) — Current Assets: 1121275000.00
CRNX balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 6441000.00
CRNX balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 6441000.00
CRNX balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 1642000.00
CRNX balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 1642000.00
CRNX balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 74155000.00
CRNX cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 1012000.00
CRNX cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 1012000.00
CRNX income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 94215000.00
CRNX income_statement (quarterly, 2025-09-30) — Diluted EPS: -1.38
CRNX income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -130091000.00
CRNX income_statement (quarterly, 2025-09-30) — EBIT: -142586000.00
CRNX income_statement (quarterly, 2025-09-30) — EBITDA: -141574000.00
CRNX income_statement (quarterly, 2025-09-30) — Earnings From Equity Interest: 0.00
CRNX cash_flow (quarterly, 2025-09-30) — Earnings Losses From Equity Investments: 0.00
CRNX cash_flow (quarterly, 2025-09-30) — End Cash Position: 112201000.00
CRNX cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 3084000.00
CRNX cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -111581000.00
CRNX cash_flow (quarterly, 2025-09-30) — Gain Loss On Sale Of PPE: 0.00
CRNX balance_sheet (quarterly, 2025-09-30) — Gains Losses Not Affecting Retained Earnings: 2194000.00
CRNX income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 52265000.00
CRNX balance_sheet (quarterly, 2025-09-30) — Gross PPE: 62567000.00
CRNX income_statement (quarterly, 2025-09-30) — Interest Income: 12544000.00
CRNX income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 12544000.00
CRNX balance_sheet (quarterly, 2025-09-30) — Invested Capital: 1072169000.00
CRNX cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: 164809000.00
CRNX cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 0.00
CRNX balance_sheet (quarterly, 2025-09-30) — Leases: 9790000.00
CRNX balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 42703000.00
CRNX balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 42703000.00
CRNX balance_sheet (quarterly, 2025-09-30) — Machinery Furniture Equipment: 2285000.00
CRNX cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 0.00
CRNX income_statement (quarterly, 2025-09-30) — Net Income: -130091000.00
CRNX income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -130091000.00
CRNX income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -130091000.00
CRNX income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -130091000.00
CRNX income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -130091000.00
CRNX cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -130091000.00
CRNX income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -130091000.00
CRNX income_statement (quarterly, 2025-09-30) — Net Interest Income: 12544000.00
CRNX cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: 165672000.00
CRNX income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 12544000.00
CRNX balance_sheet (quarterly, 2025-09-30) — Net PPE: 55524000.00
CRNX cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -863000.00
CRNX balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 1072169000.00
CRNX balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 4110000.00
CRNX balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Revenue: 4110000.00
CRNX income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -141574000.00
CRNX income_statement (quarterly, 2025-09-30) — Normalized Income: -130091000.00
CRNX cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -110718000.00
CRNX cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: 0.00
CRNX income_statement (quarterly, 2025-09-30) — Operating Income: -142586000.00
CRNX income_statement (quarterly, 2025-09-30) — Operating Revenue: 143000.00
CRNX balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 94548323.00
CRNX balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 28484000.00
CRNX balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: 2194000.00
CRNX balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: -112000.00
CRNX income_statement (quarterly, 2025-09-30) — Other Gand A: 52265000.00
CRNX income_statement (quarterly, 2025-09-30) — Other Income Expense: -49000.00
CRNX cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 755000.00
CRNX balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 19232000.00
CRNX balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 2894000.00
CRNX income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: -49000.00
CRNX balance_sheet (quarterly, 2025-09-30) — Other Properties: 50492000.00
CRNX balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 981390000.00
CRNX balance_sheet (quarterly, 2025-09-30) — Payables: 6109000.00
CRNX balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 33674000.00
CRNX balance_sheet (quarterly, 2025-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 32398000.00
CRNX balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
CRNX income_statement (quarterly, 2025-09-30) — Pretax Income: -130091000.00
CRNX cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 3084000.00
CRNX balance_sheet (quarterly, 2025-09-30) — Properties: 0.00
CRNX cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: -216700000.00
CRNX cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -863000.00
CRNX income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 1012000.00
CRNX income_statement (quarterly, 2025-09-30) — Research And Development: 90464000.00
CRNX balance_sheet (quarterly, 2025-09-30) — Restricted Cash: 500000.00
CRNX balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -1294612000.00
CRNX cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 382372000.00
CRNX income_statement (quarterly, 2025-09-30) — Selling General And Administration: 52265000.00
CRNX balance_sheet (quarterly, 2025-09-30) — Share Issued: 94548323.00
CRNX cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 22702000.00
CRNX balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 1072169000.00
CRNX balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 1072169000.00
CRNX income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
CRNX income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.00
CRNX balance_sheet (quarterly, 2025-09-30) — Total Assets: 1196031000.00
CRNX balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 1072169000.00
CRNX balance_sheet (quarterly, 2025-09-30) — Total Debt: 49144000.00
CRNX balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 1072169000.00
CRNX income_statement (quarterly, 2025-09-30) — Total Expenses: 142729000.00
CRNX balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 123862000.00
CRNX balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 74756000.00
CRNX balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 49707000.00
CRNX income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -142586000.00
CRNX balance_sheet (quarterly, 2025-09-30) — Working Capital: 1047120000.00
CRNX income_statement (annual, 2025-12-31) — +Operating Expense: 523389000.00
CRNX income_statement (quarterly, 2025-12-31) — +Operating Expense: 138751000.00
CRNX income_statement (annual, 2025-12-31) — +Total Revenue: 1249147.87
CRNX income_statement (quarterly, 2025-12-31) — +Total Revenue: 1000000.00
CRNX balance_sheet (annual, 2025-12-31) — Accounts Payable: 22611000.00
CRNX balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 22611000.00
CRNX balance_sheet (annual, 2025-12-31) — Accounts Receivable: 592000.00
CRNX balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 592000.00
CRNX balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -7952000.00
CRNX balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -7952000.00
CRNX cash_flow (annual, 2025-12-31) — Amortization Of Securities: -15425000.00
CRNX cash_flow (quarterly, 2025-12-31) — Amortization Of Securities: -2734000.00
CRNX income_statement (annual, 2025-12-31) — Basic Average Shares: 94057000.00
CRNX income_statement (quarterly, 2025-12-31) — Basic Average Shares: 95096000.00
CRNX income_statement (annual, 2025-12-31) — Basic EPS: -4.95
CRNX income_statement (quarterly, 2025-12-31) — Basic EPS: -1.29
CRNX cash_flow (annual, 2025-12-31) — Beginning Cash Position: 265845000.00
CRNX cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 112201000.00
CRNX cash_flow (annual, 2025-12-31) — Capital Expenditure: -5762000.00
CRNX cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -458000.00
CRNX balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 48541000.00
CRNX balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 48541000.00
CRNX balance_sheet (annual, 2025-12-31) — Capital Stock: 2407757000.00
CRNX balance_sheet (quarterly, 2025-12-31) — Capital Stock: 2407757000.00
CRNX balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 101536000.00
CRNX balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 101536000.00
CRNX balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 1027889000.00
CRNX balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 1027889000.00
CRNX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 40611000.00
CRNX cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 26035000.00
CRNX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: 173908000.00
CRNX cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: 57107000.00
CRNX cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -377922000.00
CRNX cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -92901000.00
CRNX cash_flow (annual, 2025-12-31) — Change In Inventory: -2022000.00
CRNX cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: -3181000.00
CRNX cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: -603000.00
CRNX cash_flow (annual, 2025-12-31) — Change In Other Working Capital: -1835000.00
CRNX cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: -707000.00
CRNX cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 28983000.00
CRNX cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 11176000.00
CRNX cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: -16511000.00
CRNX cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: 2020000.00
CRNX cash_flow (annual, 2025-12-31) — Change In Receivables: -592000.00
CRNX cash_flow (annual, 2025-12-31) — Change In Working Capital: 4842000.00
CRNX cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 9272000.00
CRNX cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -592000.00
CRNX cash_flow (annual, 2025-12-31) — Changes In Cash: -163403000.00
CRNX cash_flow (quarterly, 2025-12-31) — Changes In Cash: -9759000.00
CRNX balance_sheet (annual, 2025-12-31) — Common Stock: 2407757000.00
CRNX balance_sheet (quarterly, 2025-12-31) — Common Stock: 2407757000.00
CRNX balance_sheet (annual, 2025-12-31) — Common Stock Equity: 992083000.00
CRNX balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 992083000.00
CRNX cash_flow (annual, 2025-12-31) — Common Stock Issuance: 0.00
CRNX cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 0.00
CRNX cash_flow (annual, 2025-12-31) — Common Stock Payments: 0.00
CRNX income_statement (annual, 2025-12-31) — Cost Of Revenue: 1076000.00
CRNX balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 19159000.00
CRNX balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 19159000.00
CRNX balance_sheet (annual, 2025-12-31) — Current Assets: 1048342000.00
CRNX balance_sheet (quarterly, 2025-12-31) — Current Assets: 1048342000.00
CRNX balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 6489000.00
CRNX balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 6489000.00
CRNX balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 6489000.00
CRNX balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 6489000.00
CRNX balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 1235000.00
CRNX balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 1235000.00
CRNX balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 1235000.00
CRNX balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 1235000.00
CRNX balance_sheet (annual, 2025-12-31) — Current Liabilities: 85072000.00
CRNX balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 85072000.00
CRNX cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 3890000.00
CRNX cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 994000.00
CRNX cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 3890000.00
CRNX cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 994000.00
CRNX income_statement (annual, 2025-12-31) — Diluted Average Shares: 94057000.00
CRNX income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 95096000.00
CRNX income_statement (annual, 2025-12-31) — Diluted EPS: -4.95
CRNX income_statement (quarterly, 2025-12-31) — Diluted EPS: -1.29
CRNX income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -465317000.00
CRNX income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -122815000.00
CRNX income_statement (annual, 2025-12-31) — EBIT: -516769000.00
CRNX income_statement (quarterly, 2025-12-31) — EBIT: -133666000.00
CRNX income_statement (annual, 2025-12-31) — EBITDA: -512879000.00
CRNX income_statement (quarterly, 2025-12-31) — EBITDA: -132672000.00
CRNX income_statement (annual, 2025-12-31) — Earnings From Equity Interest: 0.00
CRNX income_statement (quarterly, 2025-12-31) — Earnings From Equity Interest: 0.00
CRNX cash_flow (annual, 2025-12-31) — Earnings Losses From Equity Investments: 0.00
CRNX cash_flow (quarterly, 2025-12-31) — Earnings Losses From Equity Investments: 0.00
CRNX cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: -106000.00
CRNX cash_flow (annual, 2025-12-31) — End Cash Position: 102336000.00
CRNX cash_flow (quarterly, 2025-12-31) — End Cash Position: 102336000.00
CRNX cash_flow (annual, 2025-12-31) — Financing Cash Flow: 40611000.00
CRNX cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 26035000.00
CRNX cash_flow (annual, 2025-12-31) — Free Cash Flow: -383684000.00
CRNX cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -93359000.00
CRNX cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of PPE: 50000.00
CRNX cash_flow (quarterly, 2025-12-31) — Gain Loss On Sale Of PPE: 8000.00
CRNX balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 1865000.00
CRNX balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 1865000.00
CRNX income_statement (annual, 2025-12-31) — General And Administrative Expense: 191331000.00
CRNX income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 53698000.00
CRNX balance_sheet (annual, 2025-12-31) — Gross PPE: 62740000.00
CRNX balance_sheet (quarterly, 2025-12-31) — Gross PPE: 62740000.00
CRNX income_statement (annual, 2025-12-31) — Gross Profit: 1000000.00
CRNX income_statement (annual, 2025-12-31) — Interest Income: 51989000.00
CRNX income_statement (quarterly, 2025-12-31) — Interest Income: 11156000.00
CRNX income_statement (annual, 2025-12-31) — Interest Income Non Operating: 51989000.00
CRNX income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 11156000.00
CRNX balance_sheet (annual, 2025-12-31) — Inventory: 2022000.00
CRNX balance_sheet (quarterly, 2025-12-31) — Inventory: 2022000.00
CRNX balance_sheet (annual, 2025-12-31) — Invested Capital: 992083000.00
CRNX balance_sheet (quarterly, 2025-12-31) — Invested Capital: 992083000.00
CRNX cash_flow (annual, 2025-12-31) — Investing Cash Flow: 173908000.00
CRNX cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: 57107000.00
CRNX cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 0.00
CRNX cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 0.00
CRNX balance_sheet (annual, 2025-12-31) — Leases: 10003000.00
CRNX balance_sheet (quarterly, 2025-12-31) — Leases: 10003000.00
CRNX balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 42052000.00
CRNX balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 42052000.00
CRNX balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 42052000.00
CRNX balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 42052000.00
CRNX balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 2285000.00
CRNX balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 2285000.00
CRNX cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 0.00
CRNX cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 0.00
CRNX income_statement (annual, 2025-12-31) — Net Income: -465317000.00
CRNX income_statement (quarterly, 2025-12-31) — Net Income: -122815000.00
CRNX income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -465317000.00
CRNX income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -122815000.00
CRNX income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -465317000.00
CRNX income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -122815000.00
CRNX income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -465317000.00
CRNX income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -122815000.00
CRNX income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -465317000.00
CRNX income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -122815000.00
CRNX cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -465317000.00
CRNX cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -122815000.00
CRNX income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -465317000.00
CRNX income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -122815000.00
CRNX income_statement (annual, 2025-12-31) — Net Interest Income: 51989000.00
CRNX income_statement (quarterly, 2025-12-31) — Net Interest Income: 11156000.00
CRNX cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: 179670000.00
CRNX cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: 57565000.00
CRNX income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 51989000.00
CRNX income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: 11156000.00
CRNX balance_sheet (annual, 2025-12-31) — Net PPE: 54788000.00
CRNX balance_sheet (quarterly, 2025-12-31) — Net PPE: 54788000.00
CRNX cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -5762000.00
CRNX cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -458000.00
CRNX balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 992083000.00
CRNX balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 992083000.00
CRNX balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 3810000.00
CRNX balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 3810000.00
CRNX balance_sheet (annual, 2025-12-31) — Non Current Deferred Revenue: 3810000.00
CRNX balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Revenue: 3810000.00
CRNX income_statement (annual, 2025-12-31) — Normalized EBITDA: -512879000.00
CRNX income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -132672000.00
CRNX income_statement (annual, 2025-12-31) — Normalized Income: -465317000.00
CRNX income_statement (quarterly, 2025-12-31) — Normalized Income: -122815000.00
CRNX cash_flow (annual, 2025-12-31) — Operating Cash Flow: -377922000.00
CRNX cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -92901000.00
CRNX cash_flow (annual, 2025-12-31) — Operating Gains Losses: 50000.00
CRNX cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: 8000.00
CRNX income_statement (annual, 2025-12-31) — Operating Income: -137751000.00
CRNX income_statement (quarterly, 2025-12-31) — Operating Income: -137751000.00
CRNX income_statement (annual, 2025-12-31) — Operating Revenue: 1249147.87
CRNX income_statement (quarterly, 2025-12-31) — Operating Revenue: 1000000.00
CRNX balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 95575000.00
CRNX balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 95575000.00
CRNX balance_sheet (annual, 2025-12-31) — Other Current Assets: 17839000.00
CRNX balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 17839000.00
CRNX balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: 1865000.00
CRNX balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 1865000.00
CRNX balance_sheet (annual, 2025-12-31) — Other Equity Interest: -112000.00
CRNX balance_sheet (quarterly, 2025-12-31) — Other Equity Interest: -112000.00
CRNX income_statement (annual, 2025-12-31) — Other Gand A: 191331000.00
CRNX income_statement (quarterly, 2025-12-31) — Other Gand A: 53698000.00
CRNX income_statement (annual, 2025-12-31) — Other Income Expense: -357000.00
CRNX income_statement (quarterly, 2025-12-31) — Other Income Expense: -125000.00
CRNX cash_flow (annual, 2025-12-31) — Other Non Cash Items: 3014000.00
CRNX cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 654000.00
CRNX balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 23127000.00
CRNX balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 23127000.00
CRNX balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 3240000.00
CRNX balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 3240000.00
CRNX income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: -357000.00
CRNX income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: -125000.00
CRNX balance_sheet (annual, 2025-12-31) — Other Properties: 50452000.00
CRNX balance_sheet (quarterly, 2025-12-31) — Other Properties: 50452000.00
CRNX balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 926353000.00
CRNX balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 926353000.00
CRNX balance_sheet (annual, 2025-12-31) — Payables: 22611000.00
CRNX balance_sheet (quarterly, 2025-12-31) — Payables: 22611000.00
CRNX balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 41770000.00
CRNX balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 41770000.00
CRNX balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 35578000.00
CRNX balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 35578000.00
CRNX balance_sheet (annual, 2025-12-31) — Preferred Stock: 0.00
CRNX balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 0.00
CRNX income_statement (annual, 2025-12-31) — Pretax Income: -465137000.00
CRNX income_statement (quarterly, 2025-12-31) — Pretax Income: -122635000.00
CRNX cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 40611000.00
CRNX cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 26035000.00
CRNX balance_sheet (annual, 2025-12-31) — Properties: 0.00
CRNX balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
CRNX cash_flow (annual, 2025-12-31) — Purchase Of Investment: -1004427000.00
CRNX cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -213646000.00
CRNX cash_flow (annual, 2025-12-31) — Purchase Of PPE: -5762000.00
CRNX cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -458000.00
CRNX balance_sheet (annual, 2025-12-31) — Receivables: 592000.00
CRNX balance_sheet (quarterly, 2025-12-31) — Receivables: 592000.00
CRNX income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 1076000.00
CRNX income_statement (annual, 2025-12-31) — Reconciled Depreciation: 3890000.00
CRNX income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 994000.00
CRNX cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: 0.00
CRNX income_statement (annual, 2025-12-31) — Research And Development: 332058000.00
CRNX income_statement (quarterly, 2025-12-31) — Research And Development: 85053000.00
CRNX balance_sheet (annual, 2025-12-31) — Restricted Cash: 0.00
CRNX balance_sheet (quarterly, 2025-12-31) — Restricted Cash: 0.00
CRNX balance_sheet (annual, 2025-12-31) — Retained Earnings: -1417427000.00
CRNX balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -1417427000.00
CRNX cash_flow (annual, 2025-12-31) — Sale Of Investment: 1184097000.00
CRNX cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 271211000.00
CRNX income_statement (annual, 2025-12-31) — Selling General And Administration: 191331000.00
CRNX income_statement (quarterly, 2025-12-31) — Selling General And Administration: 53698000.00
CRNX balance_sheet (annual, 2025-12-31) — Share Issued: 95575000.00
CRNX balance_sheet (quarterly, 2025-12-31) — Share Issued: 95575000.00
CRNX cash_flow (annual, 2025-12-31) — Stock Based Compensation: 91024000.00
CRNX cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 21720000.00
CRNX balance_sheet (annual, 2025-12-31) — Stockholders Equity: 992083000.00
CRNX balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 992083000.00
CRNX balance_sheet (annual, 2025-12-31) — Tangible Book Value: 992083000.00
CRNX balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 992083000.00
CRNX income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
CRNX income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
CRNX income_statement (annual, 2025-12-31) — Tax Provision: 180000.00
CRNX income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.21
CRNX income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.00
CRNX balance_sheet (annual, 2025-12-31) — Total Assets: 1126257000.00
CRNX balance_sheet (quarterly, 2025-12-31) — Total Assets: 1126257000.00
CRNX balance_sheet (annual, 2025-12-31) — Total Capitalization: 992083000.00
CRNX balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 992083000.00
CRNX balance_sheet (annual, 2025-12-31) — Total Debt: 48541000.00
CRNX balance_sheet (quarterly, 2025-12-31) — Total Debt: 48541000.00
CRNX balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 992083000.00
CRNX balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 992083000.00
CRNX income_statement (annual, 2025-12-31) — Total Expenses: 524465000.00
CRNX income_statement (quarterly, 2025-12-31) — Total Expenses: 139827000.00
CRNX balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 134174000.00
CRNX balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 134174000.00
CRNX balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 77915000.00
CRNX balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 77915000.00
CRNX balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 49102000.00
CRNX balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 49102000.00
CRNX income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -516769000.00
CRNX income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -133666000.00
CRNX balance_sheet (annual, 2025-12-31) — Working Capital: 963270000.00
CRNX balance_sheet (quarterly, 2025-12-31) — Working Capital: 963270000.00
CRNX income_statement (quarterly, 2026-03-31) — +Operating Expense: 150912000.00
CRNX income_statement (quarterly, 2026-03-31) — +Total Revenue: 847599.49
CRNX balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 12879000.00
CRNX balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 5683000.00
CRNX balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -9088000.00
CRNX cash_flow (quarterly, 2026-03-31) — Amortization Of Securities: -2220000.00
CRNX income_statement (quarterly, 2026-03-31) — Basic Average Shares: 104099000.00
CRNX income_statement (quarterly, 2026-03-31) — Basic EPS: -1.23
CRNX cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 102336000.00
CRNX cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -820000.00
CRNX balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 47855000.00
CRNX balance_sheet (quarterly, 2026-03-31) — Capital Stock: 2828204000.00
CRNX balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 114341000.00
CRNX balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 1291306000.00
CRNX cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 389875000.00
CRNX cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -252359000.00
CRNX cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -124703000.00
CRNX cash_flow (quarterly, 2026-03-31) — Change In Inventory: -909000.00
CRNX cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: -685000.00
CRNX cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: -428000.00
CRNX cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -12064000.00
CRNX cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: -7024000.00
CRNX cash_flow (quarterly, 2026-03-31) — Change In Receivables: -5091000.00
CRNX cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -26201000.00
CRNX cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: -5091000.00
CRNX cash_flow (quarterly, 2026-03-31) — Changes In Cash: 12813000.00
CRNX balance_sheet (quarterly, 2026-03-31) — Common Stock: 2828204000.00
CRNX balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 1280646000.00
CRNX cash_flow (quarterly, 2026-03-31) — Common Stock Issuance: 380514000.00
CRNX cash_flow (quarterly, 2026-03-31) — Common Stock Payments: -578000.00
CRNX income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 200000.00
CRNX balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 24608000.00
CRNX balance_sheet (quarterly, 2026-03-31) — Current Assets: 1322414000.00
CRNX balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 6536000.00
CRNX balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 6536000.00
CRNX balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 1271000.00
CRNX balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 1271000.00
CRNX balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 71086000.00
CRNX cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 1160000.00
CRNX cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 1160000.00
CRNX income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 104099000.00
CRNX income_statement (quarterly, 2026-03-31) — Diluted EPS: -1.23
CRNX income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -127845000.00
CRNX income_statement (quarterly, 2026-03-31) — EBIT: -140378000.00
CRNX income_statement (quarterly, 2026-03-31) — EBITDA: -139218000.00
CRNX cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -8000.00
CRNX cash_flow (quarterly, 2026-03-31) — End Cash Position: 115141000.00
CRNX cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 389875000.00
CRNX balance_sheet (quarterly, 2026-03-31) — Finished Goods: 29000.00
CRNX cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -125523000.00
CRNX cash_flow (quarterly, 2026-03-31) — Gain Loss On Sale Of PPE: 20000.00
CRNX balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -1254000.00
CRNX income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 50831000.00
CRNX balance_sheet (quarterly, 2026-03-31) — Gross PPE: 62375000.00
CRNX income_statement (quarterly, 2026-03-31) — Gross Profit: 647599.49
CRNX income_statement (quarterly, 2026-03-31) — Interest Income: 12664000.00
CRNX income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 12664000.00
CRNX balance_sheet (quarterly, 2026-03-31) — Inventory: 3064000.00
CRNX balance_sheet (quarterly, 2026-03-31) — Invested Capital: 1280646000.00
CRNX cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -252359000.00
CRNX cash_flow (quarterly, 2026-03-31) — Issuance Of Capital Stock: 380514000.00
CRNX balance_sheet (quarterly, 2026-03-31) — Leases: 10127000.00
CRNX balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 41319000.00
CRNX balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 41319000.00
CRNX balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 2293000.00
CRNX cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: 379936000.00
CRNX income_statement (quarterly, 2026-03-31) — Net Income: -127845000.00
CRNX income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -127845000.00
CRNX income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -127845000.00
CRNX income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -127845000.00